These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29781324)

  • 1. How to address the placebo response in the prescription SSRIs and SNRIs in children and adolescents.
    Koechlin H; Kossowsky J; Gaab J; Locher C
    Expert Opin Drug Saf; 2018 Jun; 17(6):537-540. PubMed ID: 29781324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, and Placebo for Common Psychiatric Disorders Among Children and Adolescents: A Systematic Review and Meta-analysis.
    Locher C; Koechlin H; Zion SR; Werner C; Pine DS; Kirsch I; Kessler RC; Kossowsky J
    JAMA Psychiatry; 2017 Oct; 74(10):1011-1020. PubMed ID: 28854296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review and meta-analysis: Dose-response curve of SSRIs and SNRIs in anxiety disorders.
    Jakubovski E; Johnson JA; Nasir M; Müller-Vahl K; Bloch MH
    Depress Anxiety; 2019 Mar; 36(3):198-212. PubMed ID: 30479005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.
    Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
    Cochrane Database Syst Rev; 2015 Apr; 4(4):CD002919. PubMed ID: 25829028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults.
    Sobieraj DM; Martinez BK; Hernandez AV; Coleman CI; Ross JS; Berg KM; Steffens DC; Baker WL
    J Am Geriatr Soc; 2019 Aug; 67(8):1571-1581. PubMed ID: 31140587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials.
    Huang KL; Lu WC; Wang YY; Hu GC; Lu CH; Lee WY; Hsu CC
    Aust N Z J Psychiatry; 2014 Jul; 48(7):663-71. PubMed ID: 24604920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anti-inflammatory mechanism of antidepressants - SSRIs, SNRIs.
    Gałecki P; Mossakowska-Wójcik J; Talarowska M
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt C):291-294. PubMed ID: 28342944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of serotonin reuptake inhibitors (SSRI) and serotonin noradrenaline reuptake inhibitors (SNRI) for children and adolescents with anxiety disorders: a systematic review and meta-analysis.
    Stefánsdóttir ÍH; Ivarsson T; Skarphedinsson G
    Nord J Psychiatry; 2023 Feb; 77(2):137-146. PubMed ID: 35587815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: A 3-level network meta-analysis.
    Gosmann NP; Costa MA; Jaeger MB; Motta LS; Frozi J; Spanemberg L; Manfro GG; Cuijpers P; Pine DS; Salum GA
    PLoS Med; 2021 Jun; 18(6):e1003664. PubMed ID: 34111122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of abnormal uterine bleeding associated with high-affinity compared with low-affinity serotonin and norepinephrine reuptake inhibitors.
    Engler J; Filliter C; Montastruc F; Abenhaim H; Rej S; Renoux C
    J Affect Disord; 2024 Apr; 350():813-821. PubMed ID: 38246277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review on the genotoxic effect of serotonin and norepinephrine reuptake inhibitors (SNRIs) antidepressants.
    Ahmadimanesh M; Balarastaghi S; Rashedinia M; Yazdian-Robati R
    Psychopharmacology (Berl); 2020 Jul; 237(7):1909-1915. PubMed ID: 32529266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term harms from previous use of selective serotonin reuptake inhibitors: A systematic review.
    Danborg PB; Valdersdorf M; Gøtzsche PC
    Int J Risk Saf Med; 2019; 30(2):59-71. PubMed ID: 30714974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [TREATMENT OF SEROTONIN AND NOREPINEPHRINE REUPTAKE INHIBITORS (SSRIS AND SNRIS) DURING PREGNANCY AND LACTATION].
    Rozner L; Aisenberg Romano G; Klieger C; Bloch M
    Harefuah; 2023 Feb; 162(2):86-91. PubMed ID: 36916077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors as adjuncts for postoperative pain management: systematic review and meta-analysis of randomised controlled trials.
    Wang L; Tobe J; Au E; Tran C; Jomy J; Oparin Y; Couban RJ; Paul J
    Br J Anaesth; 2022 Jan; 128(1):118-134. PubMed ID: 34756632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SSRIs in the Treatment of Depression: A Pharmacological CUL-DE-SAC?
    Cowen PJ
    Curr Top Behav Neurosci; 2024; 66():1-19. PubMed ID: 37922101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
    Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD011681. PubMed ID: 25931277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin-Norepinephrine Reuptake Inhibitors and the Risk of AKI: A Cohort Study of Eight Administrative Databases and Meta-Analysis.
    Renoux C; Lix LM; Patenaude V; Bresee LC; Paterson JM; Lafrance JP; Tamim H; Mahmud SM; Alsabbagh MW; Hemmelgarn B; Dormuth CR; Ernst P;
    Clin J Am Soc Nephrol; 2015 Oct; 10(10):1716-22. PubMed ID: 26231193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Empirically Supported Use of Psychiatric Medications in Adolescents and Adults with IBD.
    Thorkelson G; Bielefeldt K; Szigethy E
    Inflamm Bowel Dis; 2016 Jun; 22(6):1509-22. PubMed ID: 27167571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Antidepressant Dose and Class on Treatment Response in Pediatric Anxiety Disorders: A Meta-Analysis.
    Strawn JR; Mills JA; Sauley BA; Welge JA
    J Am Acad Child Adolesc Psychiatry; 2018 Apr; 57(4):235-244.e2. PubMed ID: 29588049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerability of concomitant use of selective serotonin reuptake inhibitors or serotonin-norepinephrine reuptake inhibitors and oxymorphone extended release.
    Peniston JH; Hu X; Potts SL; Wieman MS; Turk DC
    Postgrad Med; 2012 Mar; 124(2):114-22. PubMed ID: 22437221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.